Dietary fish oil reduces systemic inflammation and ameliorates sepsis-induced liver injury by up-regulating the peroxisome proliferator-activated receptor gamma-mediated pathway in septic mice

Journal of Nutritional Biochemistry

Volumn 25, Issue 1, 2014, Pages 19-25

  Li, Cheng Chung ^a   Yang, Hui Ting ^b   Hou, Yu Chen ^a   Chiu, Yen Shuo ^a,c   Chiu, Wan Chun ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Fish oil; Inducible nitric oxide synthase; NF B p65; Peroxisome proliferators activated receptor gamma; Sepsis

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; FISH OIL; I KAPPA B ALPHA; I KAPPA B BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; NITRITE; PERITONEAL DIALYSIS FLUID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN; PROSTAGLANDIN E2; SOYBEAN OIL; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; DNA BINDING; EXPERIMENTAL MOUSE; GENE EXPRESSION; INFLAMMATION; LIGATION; LIMIT OF DETECTION; LIVER FUNCTION; LIVER HOMOGENATE; LIVER INJURY; MALE; MOUSE; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; PROTEIN EXPRESSION; PUNCTURE; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEPSIS; SEPSIS INDUCED LIVER INJURY; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATION; THERAPY EFFECT; UPREGULATION;

FISH OIL; INDUCIBLE NITRIC OXIDE SYNTHASE; NF-ΚB P65; PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR GAMMA; SEPSIS;

ANIMALS; BIOLOGICAL MARKERS; FATTY ACIDS, OMEGA-3; FISH OILS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED ICR; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PPAR GAMMA; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; UP-REGULATION;

EID: 84889570371     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.08.010     Document Type: Article

References (47)

1. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
2. Yang S., Koo D.J., Zhou M., Chaudry I.H., Wang P. Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol 2000, 279:G1274-G1281.
3. Wang J.H., Redmond H.P., Watson R.W., Bouchier-Hayes D. Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am J Physiol 1995, 269:G297-G304.
4. Hebert P.C., Drummond A.J., Singer J., Bernard G.R., Russell J.A. A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993, 104:230-235.
5. Wang P., Chaudry I.H. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996, 270:R927-R938.
6. Szabo G, Romics L, Jr., Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clinics in liver disease. 2002;6:1045-66, x.
7. Chiu W.C., Wang Y.C., Chien Y.W., Hou Y.C., Hu Y.M., Yeh S.L. Effects of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in hypercholesterolemic mice with sepsis. J Nutr Biochem 2009, 20:254-260.
8. Rocchi S., Auwerx J. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. Ann Med 1999, 31:342-351.
9. Zhou M., Wu R., Dong W., Jacob A., Wang P. Endotoxin downregulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release. Am J Physiol Regul Integr Comp Physiol 2008, 294:R84-R92.
10. Higuchi S., Wu R., Zhou M., Ravikumar T.S., Wang P. Downregulation of hepatic cytochrome P-450 isoforms and PPAR-gamma: their role in hepatic injury and proinflammatory responses in a double-hit model of hemorrhage and sepsis. J Surg Res 2007, 137:46-52.
11. Zingarelli B., Sheehan M., Hake P.W., O'Connor M., Denenberg A., Cook J.A. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 2003, 171:6827-6837.
12. Chen D., Pan J., Du B., Sun D. Induction of the heat shock response in vivo inhibits NF-kappaB activity and protects murine liver from endotoxemia-induced injury. J Clin Immunol 2005, 25:452-461.
13. Chen H.W., Kuo H.T., Wang S.J., Lu T.S., Yang R.C. In vivo heat shock protein assembles with septic liver NF-kappaB/I-kappaB complex regulating NF-kappaB activity. Shock 2005, 24:232-238.
14. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002, 21:495-505.
15. Sierra S., Lara-Villoslada F., Comalada M., Olivares M., Xaus J. Dietary fish oil n-3 fatty acids increase regulatory cytokine production and exert anti-inflammatory effects in two murine models of inflammation. Lipids 2006, 41:1115-1125.
16. Marion-Letellier R., Dechelotte P., Iacucci M., Ghosh S. Dietary modulation of peroxisome proliferator-activated receptor gamma. Gut 2009, 58:586-593.
17. Marion-Letellier R., Butler M., Dechelotte P., Playford R.J., Ghosh S. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells-potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation. Am J Clin Nutr 2008, 87:939-948.
18. Zuniga J., Venegas F., Villarreal M., Nunez D., Chandia M., Valenzuela R., et al. Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat. Free Radic Res 2010, 44:854-863.
19. Lanza-Jacoby S., Flynn J.T., Miller S. Parenteral supplementation with a fish-oil emulsion prolongs survival and improves rat lymphocyte function during sepsis. Nutrition 2001, 17:112-116.
20. Ayala A., Deol Z.K., Lehman D.L., Herdon C.D., Chaudry I.H. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 1994, 56:579-585.
21. Hillegass L.M., Griswold D.E., Brickson B., Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990, 24:285-295.
22. Kaplan J.M., Cook J.A., Hake P.W., O'Connor M., Burroughs T.J., Zingarelli B. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock 2005, 24:59-65.
23. Rittirsch D., Huber-Lang M.S., Flierl M.A., Ward P.A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009, 4:31-36.
24. Hsu C.S., Chiu W.C., Yeh C.L., Hou Y.C., Chou S.Y., Yeh S.L. Dietary fish oil enhances adhesion molecule and interleukin-6 expression in mice with polymicrobial sepsis. Br J Nutr 2006, 96:854-860.
25. Chiu W.C., Hou Y.C., Yeh C.L., Hu Y.M., Yeh S.L. Effect of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in diabetic mice with sepsis. Br J Nutr 2007, 97:685-691.
26. Broughton K.S., Johnson C.S., Pace B.K., Liebman M., Kleppinger K.M. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997, 65:1011-1017.
27. Carlstedt F., Lind L., Lindahl B. Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease. J Intern Med 1997, 242:361-365.
28. Avontuur J.A., Stam T.C., Jongen-Lavrencic M., van Amsterdam J.G., Eggermont A.M., Bruining H.A. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock. Intensive Care Med 1998, 24:673-679.
29. Strand O.A., Leone A., Giercksky K.E., Kirkeboen K.A. Nitric oxide indices in human septic shock. Crit Care Med 2000, 28:2779-2785.
30. Wu H.P., Chen C.K., Chung K., Tseng J.C., Hua C.C., Liu Y.C., et al. Serial cytokine levels in patients with severe sepsis. Inflamm Res 2009, 58:385-393.
31. Song G.Y., Chung C.S., Chaudry I.H., Ayala A. What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant?. Surgery 1999, 126:378-383.
32. Osuchowski M.F., Welch K., Siddiqui J., Remick D.G. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006, 177:1967-1974.
33. Klebanoff S.J. Myeloperoxidase: friend and foe. J Leukoc Biol 2005, 77:598-625.
34. Portanova J.P., Zhang Y., Anderson G.D., Hauser S.D., Masferrer J.L., Seibert K., et al. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 1996, 184:883-891.
35. Kothari N., Keshari R.S., Bogra J., Kohli M., Abbas H., Malik A., et al. Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J Crit Care 2011, 26:435e1-435e7.
36. Siddiqui A.M., Cui X., Wu R., Dong W., Zhou M., Hu M., et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 2006, 34:1874-1882.
37. Araujo C.V., Estato V., Tibirica E., Bozza P.T., Castro-Faria-Neto H.C., Silva A.R. PPAR gamma activation protects the brain against microvascular dysfunction in sepsis. Microvasc Res 2012, 84:218-221.
38. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004, 5:104-112.
39. Li M., Pascual G., Glass C.K. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol. 2000, 20:4699-4707.
40. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
41. Guyton K., Zingarelli B., Ashton S., Teti G., Tempel G., Reilly C., et al. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. Shock 2003, 20:56-62.
42. Huang F., Wei H., Luo H., Jiang S., Peng J. EPA inhibits the inhibitor of kappaBalpha (IkappaBalpha)/NF-kappaB/muscle RING finger 1 pathway in C2C12 myotubes in a PPARgamma-dependent manner. Br J Nutr 2011, 105:348-356.
43. Sakurai H., Chiba H., Miyoshi H., Sugita T., Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999, 274:30353-30356.
44. Niederberger E., Geisslinger G. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy?. FASEB J 2008, 22:3432-3442.
45. Dhainaut J.F., Marin N., Mignon A., Vinsonneau C. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001, 29:S42-S47.
46. Murata M., Kawanishi S. Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. Biochem Biophys Res Commun 2004, 316:123-128.
47. Piconi L., Quagliaro L., Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003, 41:1144-1149.